PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-29.67%
Both yoy net incomes decline, with CRON.TO at -159.63%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
5.08%
Less D&A growth vs. CRON.TO's 23.98%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
99.06%
Well above CRON.TO's 100.25% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
179.35%
Less SBC growth vs. CRON.TO's 2674.15%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
285.27%
Well above CRON.TO's 23.00% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-100.00%
Both yoy AR lines negative, with CRON.TO at -93.50%. Martin Whitman would suspect an overall sector lean approach or softer demand.
100.00%
Inventory growth well above CRON.TO's 23.82%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
100.00%
A yoy AP increase while CRON.TO is negative at -69.37%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-100.00%
Negative yoy usage while CRON.TO is 78.27%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-1179.06%
Negative yoy while CRON.TO is 95.42%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
412.48%
Some CFO growth while CRON.TO is negative at -17.71%. John Neff would note a short-term liquidity lead over the competitor.
-1123.65%
Both yoy lines negative, with CRON.TO at -53.40%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
25.87%
Purchases growth of 25.87% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
No Data
No Data available this quarter, please select a different quarter.
729.29%
We have some outflow growth while CRON.TO is negative at -397.45%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-295.26%
Both yoy lines negative, with CRON.TO at -330.42%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
9863.41%
Stock issuance far above CRON.TO's 4456.10%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.